Clinical Trial Update: Creon After Pancreatic Surgery [Phase 4]

View source ↗

Summary

Abbott's Creon (pancrelipase) pancreatic enzyme replacement therapy completed its Phase 4 trial for pancreatic insufficiency after pancreatic surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Insufficiency

Drugs mentioned

• Creon (pancrelipase)

Snippet

Sponsor: Abbott Products | Conditions: Pancreatic Insufficiency | Phase 4 | Status: COMPLETED